ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr | ₹3,245 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹3,995 Cr |
Mar2023 | ₹3,707 Cr |
Mar2022 | ₹4,805 Cr |
Mar2021 | ₹3,604 Cr |
Mar2020 | ₹3,245 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3,995 Cr | 7.75 | |
Mar2023 | ₹3,707 Cr | -22.85 | |
Mar2022 | ₹4,805 Cr | 33.33 | |
Mar2021 | ₹3,604 Cr | 11.08 | |
Mar2020 | ₹3,245 Cr | - |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹61,652.6 Cr | 2.2% | -4.1% | 2.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 2.2% |
-4.1% |
2.6% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses